Table 3.
HR* | (95% CI†) | |
---|---|---|
Background population controls not treated with MHID‡ | 1.00 (Ref) | |
Hospital diagnosis of prostate disease not treated with MHID | 1.78 | (1.57–2.01) |
Hospital diagnosis of prostate disease treated with MHID | 1.75 | (1.43–2.15) |
*HR, hazard ratio.
†CI, confidence interval.
‡Male-hormone interfering drugs.